Translational horizons in stem cell therapy for osteonecrosis of the femoral head: a journey from basic research to clinical practice through bibliometric insights.
Basic research
Bibliometric
Clinical practice
Osteonecrosis of the femoral head
Stem cell therapy
Journal
Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741
Informations de publication
Date de publication:
30 Oct 2024
30 Oct 2024
Historique:
received:
17
04
2024
accepted:
19
10
2024
medline:
31
10
2024
pubmed:
31
10
2024
entrez:
31
10
2024
Statut:
epublish
Résumé
Osteonecrosis of the femoral head (ONFH) significantly impacts young and middle-aged adults, with steroid use implicated in many cases. Traditional treatments have limited efficacy, prompting a shift towards innovative approaches, such as stem cell therapy, offering less invasive regenerative solutions. Using bibliometric analysis from 1997 to 2023, we identified 392 articles on stem cell therapy for ONFH from the Web of Science Core Collection and analysed them using VOSviewer and CiteSpace to identify key trends and research directions. From 1997 to 2023, stem cell therapy for ONFH research expanded significantly, with 392 articles evidencing global collaboration, particularly from China, the United States and South Korea. The field is characterised by 158 core authors across 26 clusters and contributions from 417 institutions in 104 research clusters, with Shanghai Jiao Tong University as a notable leader. This research is disseminated through 23 journal clusters, emphasising interdisciplinary work, with Clinical Orthopaedics and Related Research among the most influential journals. Key findings include the identification of the most influential papers, highlighting advances, such as use of autologous mesenchymal stem cells (MSCs) and innovative delivery mechanisms. High-frequency keyword analysis further mapped the evolution of the field, from basic mechanisms to advanced therapies, underscoring a trend towards more targeted stem cell treatments for ONFH. Stem cell therapy for ONFH has advanced significantly, showcasing a successful transition from basic research to clinical practice, particularly highlighted by developments in use of autologous MSCs and delivery methods. Future research will focus on refining therapies through exosome technology, targeted modulation of stress and inflammation and integration with surgical techniques, with the aim of tailored patient care and improved ONFH outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Osteonecrosis of the femoral head (ONFH) significantly impacts young and middle-aged adults, with steroid use implicated in many cases. Traditional treatments have limited efficacy, prompting a shift towards innovative approaches, such as stem cell therapy, offering less invasive regenerative solutions.
METHODS
METHODS
Using bibliometric analysis from 1997 to 2023, we identified 392 articles on stem cell therapy for ONFH from the Web of Science Core Collection and analysed them using VOSviewer and CiteSpace to identify key trends and research directions.
RESULTS
RESULTS
From 1997 to 2023, stem cell therapy for ONFH research expanded significantly, with 392 articles evidencing global collaboration, particularly from China, the United States and South Korea. The field is characterised by 158 core authors across 26 clusters and contributions from 417 institutions in 104 research clusters, with Shanghai Jiao Tong University as a notable leader. This research is disseminated through 23 journal clusters, emphasising interdisciplinary work, with Clinical Orthopaedics and Related Research among the most influential journals. Key findings include the identification of the most influential papers, highlighting advances, such as use of autologous mesenchymal stem cells (MSCs) and innovative delivery mechanisms. High-frequency keyword analysis further mapped the evolution of the field, from basic mechanisms to advanced therapies, underscoring a trend towards more targeted stem cell treatments for ONFH.
CONCLUSION
CONCLUSIONS
Stem cell therapy for ONFH has advanced significantly, showcasing a successful transition from basic research to clinical practice, particularly highlighted by developments in use of autologous MSCs and delivery methods. Future research will focus on refining therapies through exosome technology, targeted modulation of stress and inflammation and integration with surgical techniques, with the aim of tailored patient care and improved ONFH outcomes.
Identifiants
pubmed: 39478610
doi: 10.1186/s12967-024-05784-6
pii: 10.1186/s12967-024-05784-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
982Subventions
Organisme : National Natural Science Foundation of China
ID : 82272489
Organisme : National Natural Science Foundation of China
ID : 82203588
Organisme : TaiShan Scholars Project Special Fund
ID : NO.tsqn202306396
Organisme : Qingdao Traditional Chinese Medicine Science and Technology Project
ID : 2021-zyym28
Organisme : Science and technology Development Project of Shandong Geriatric Society
ID : LKJGG2021W082
Informations de copyright
© 2024. The Author(s).
Références
Liu LH, Zhang QY, Sun W, Li ZR, Gao FQ. Corticosteroid-induced osteonecrosis of the femoral head: detection, diagnosis, and treatment in earlier stages. Chin Med J (Engl). 2017;130(21):2601–7. https://doi.org/10.4103/0366-6999.217094 . Epub 2017/10/27.
doi: 10.4103/0366-6999.217094
pubmed: 29067959
Li L, Ding Y, Liu B, Wang Z, Carlone DL, Yu X, et al. Transcriptome landscape of the late-stage alcohol-induced osteonecrosis of the human femoral head. Bone. 2021;150:116012. https://doi.org/10.1016/j.bone.2021.116012 . Epub 2021/05/22.
doi: 10.1016/j.bone.2021.116012
pubmed: 34020076
Zhang Y, Zhuang Z, Wei Q, Li P, Li J, Fan Y, et al. Inhibition of mir-93-5p promotes osteogenic differentiation in a rabbit model of trauma-induced osteonecrosis of the femoral head. FEBS Open Bio. 2021;11(8):2152–65. PubMed PMID: 34092046; PubMed Central PMCID: PMCPMC8329948.
doi: 10.1002/2211-5463.13218
pubmed: 34092046
pmcid: 8329948
Wang T, Azeddine B, Mah W, Harvey EJ, Rosenblatt D, Séguin C. Osteonecrosis of the femoral head: genetic basis. Int Orthop. 2019;43(3):519–30. https://doi.org/10.1007/s00264-018-4172-8 . Epub 2018/10/18.
doi: 10.1007/s00264-018-4172-8
pubmed: 30328481
Meng K, Liu Y, Ruan L, Chen L, Chen Y, Liang Y. Suppression of apoptosis in osteocytes, the potential way of natural medicine in the treatment of osteonecrosis of the femoral head. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie. 2023;162:114403. https://doi.org/10.1016/j.biopha.2023.114403 . Epub 2023/04/02.
doi: 10.1016/j.biopha.2023.114403
Zhao D, Zhang F, Wang B, Liu B, Li L, Kim SY et al. Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version). J Orthop Translat. 2020;21:100 – 10. Epub 2020/04/21. doi: 10.1016/j.jot.2019.12.004. PubMed PMID: 32309135; PubMed Central PMCID: PMCPMC7152793.
Chen C, Zhao X, Luo Y, Li B, Li Q, Zhao C, et al. Imbalanced T-Cell subsets may facilitate the occurrence of osteonecrosis of the femoral head. J Inflamm Res. 2022;15:4159–69. https://doi.org/10.2147/jir.S367214 . Epub 2022/08/02.
doi: 10.2147/jir.S367214
pubmed: 35912401
pmcid: 9328079
Song Y, Du Z, Chen B, Ren M, Yang Q, Sui Y, et al. Association of SREBP2 gene polymorphisms with the risk of osteonecrosis of the femoral head relates to gene expression and lipid metabolism disorders. Mol Med Rep. 2017;16(5):7145–53. https://doi.org/10.3892/mmr.2017.7473 . Epub 2017/09/14.
doi: 10.3892/mmr.2017.7473
pubmed: 28901487
Helbig L, Simank HG, Kroeber M, Schmidmaier G, Grützner PA, Guehring T. Core decompression combined with implantation of a demineralised bone matrix for non-traumatic osteonecrosis of the femoral head. Arch Orthop Trauma Surg. 2012;132(8):1095–103. https://doi.org/10.1007/s00402-012-1526-3 . Epub 2012/05/09.
doi: 10.1007/s00402-012-1526-3
pubmed: 22566110
Li D, Li M, Liu P, Zhang Y, Ma L, Xu F. Core decompression or quadratus femoris muscle pedicle bone grafting for nontraumatic osteonecrosis of the femoral head: a randomized control study. Indian J Orthop. 2016;50(6):629–35. https://doi.org/10.4103/0019-5413.193478 . Epub 2016/12/03.
doi: 10.4103/0019-5413.193478
pubmed: 27904218
pmcid: 5122258
Grübl A, Chiari C, Gruber M, Kaider A, Gottsauner-Wolf F. Cementless total hip arthroplasty with a tapered, rectangular titanium stem and a threaded cup: a minimum ten-year follow-up. J bone Joint Surg Am Volume. 2002;84(3):425–31. https://doi.org/10.2106/00004623-200203000-00014 . Epub 2002/03/12.
doi: 10.2106/00004623-200203000-00014
McMahon SJ, Christmas M, Pierrepont J, McMahon J, McMahon R. The Accuracy of Acetabular Cup Positioning using patient-specific 3D Orientation Guidance in total hip arthroplasty. Surg Technol Int. 2020;36:426–31. Epub 2020/05/03. PubMed PMID: 32359167.
pubmed: 32359167
Xu Y, Jiang Y, Xia C, Wang Y, Zhao Z, Li T. Stem cell therapy for osteonecrosis of femoral head: opportunities and challenges. Regen Ther. 2020;15:295–304. PubMed PMID: 33426232; PubMed Central PMCID: PMCPMC7770428.
doi: 10.1016/j.reth.2020.11.003
pubmed: 33426232
pmcid: 7770428
Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Rel Res. 2002;40514–23. https://doi.org/10.1097/01.blo.0000038472.05771.79 . PubMed PMID: WOS:000179861400003.
Hernigou P, Dubory A, Homma Y, Guissou I, Lachaniette CHF, Chevallier N, et al. Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients. Int Orthop. 2018;42(7):1639–49. https://doi.org/10.1007/s00264-018-3941-8 . PubMed PMID: WOS:000436405000029.
doi: 10.1007/s00264-018-3941-8
pubmed: 29744647
Wu T, Jiang Y, Tian H, Shi W, Wang Y, Li T. Systematic analysis of hip-preserving treatment for early osteonecrosis of the femoral head from the perspective of bibliometrics (2010–2023). J Orthop Surg Res. 2023;18(1):959. https://doi.org/10.1186/s13018-023-04435-8 . Epub 2023/12/14.
doi: 10.1186/s13018-023-04435-8
pubmed: 38093378
pmcid: 10717545
Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, web of Science, and Google Scholar: strengths and weaknesses. Faseb J. 2008;22(2):338–42. https://doi.org/10.1096/fj.07-9492LSF . PubMed PMID: WOS:000252822600003.
doi: 10.1096/fj.07-9492LSF
pubmed: 17884971
Wang Q, Waltman L. Large-scale analysis of the accuracy of the journal classification systems of web of Science and Scopus. J Informetrics. 2016;10(2):347–64. https://doi.org/10.1016/j.joi.2016.02.003 . PubMed PMID: WOS:000377413800003.
doi: 10.1016/j.joi.2016.02.003
Nicolaisen J. Bibliometrics and citation analysis: from the Science Citation Index to Cybermetrics. J Am Soc Inf Sci Tec. 2010;61(1):205–7. https://doi.org/10.1002/asi.21181 . PubMed PMID: WOS:000273155100018.
doi: 10.1002/asi.21181
Chen CM, CiteSpace II. Detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Tec. 2006;57(3):359–77. https://doi.org/10.1002/asi.20317 . PubMed PMID: WOS:000234932600008.
doi: 10.1002/asi.20317
Eck NJPV, Waltman LRJERSRM. VOSviewer: A Computer Program for Bibliometric Mapping. 2009;84(2):523 – 38. https://doi.org/10.1007/s11192-009-0146-3
Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J bone Joint Surg Am Volume. 2004;86(6):1153–60. https://doi.org/10.2106/00004623-200406000-00006 . Epub 2004/06/03.
doi: 10.2106/00004623-200406000-00006
Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011;49(5):1005–9. https://doi.org/10.1016/j.bone.2011.07.032 . PubMed PMID: WOS:000296405100010.
doi: 10.1016/j.bone.2011.07.032
pubmed: 21821156
Zhao DW, Cui DP, Wang BJ, Tian FD, Guo L, Yang L, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50(1):325–30. PubMed PMID: WOS:000299064200041.
doi: 10.1016/j.bone.2011.11.002
pubmed: 22094904
Kawate K, Yajima H, Ohgushi H, Kotobuki N, Sugimoto K, Ohmura T, et al. Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. Artif Organs. 2006;30(12):960–2. https://doi.org/10.1111/j.1525-1594.2006.00333 . .x. PubMed PMID: WOS:000242635400009.
doi: 10.1111/j.1525-1594.2006.00333
pubmed: 17181837
Feng Q, Xu JK, Zhang KY, Yao H, Zheng NY, Zheng LZ, et al. Dynamic and cell-infiltratable hydrogels as Injectable Carrier of Therapeutic Cells and drugs for treating challenging bone defects. ACS Cent Sci. 2019;5(3):440–50. https://doi.org/10.1021/acscentsci.8b00764 . PubMed PMID: WOS:000462498900010.
doi: 10.1021/acscentsci.8b00764
pubmed: 30937371
pmcid: 6439455
Hernigou P, Poignard A, Zilber S, Rouard H. Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop. 2009;43(1):40–5. https://doi.org/10.4103/0019-5413.45322 . PubMed PMID: WOS:000270729300008.
doi: 10.4103/0019-5413.45322
pubmed: 19753178
pmcid: 2739495
Wei BF, Wei W, Zhao BX, Guo XX, Liu S. Long non-coding RNA HOTAIR inhibits mir-17-5p to regulate osteogenic differentiation and proliferation in nontraumatic osteonecrosis of femoral head. PLoS ONE. 2017;12(2):14. https://doi.org/10.1371/journal.pone.0169097 . PubMed PMID: WOS:000394424500003.
doi: 10.1371/journal.pone.0169097
Hernigou P, Beaujean F, Lambotte JC. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg-Br Vol. 1999;81B(2):349–55. https://doi.org/10.1302/0301-620x.81b2.8818 . PubMed PMID: WOS:000079501900033.
doi: 10.1302/0301-620x.81b2.8818
Cui Q, Wang GJ, Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J Bone Joint Surg-Am Vol. 1997;79A(7):1054–63. https://doi.org/10.2106/00004623-199707000-00012 . PubMed PMID: WOS:A1997XM01500012.
doi: 10.2106/00004623-199707000-00012
Liu XL, Li Q, Niu X, Hu B, Chen SB, Song WQ, et al. Exosomes secreted from Human-Induced pluripotent stem cell-derived mesenchymal stem cells prevent osteonecrosis of the femoral head by promoting angiogenesis. Int J Biol Sci. 2017;13(2):232–44. https://doi.org/10.7150/ijbs.16951 . PubMed PMID: WOS:000396426600010.
doi: 10.7150/ijbs.16951
pubmed: 28255275
pmcid: 5332877
Price DJDS, Merton RK, Garfield EJcup. Little Science, Big Science and Beyond. 1986.
Sun Y, Feng Y, Zhang CQ. The effect of bone marrow mononuclear cells on vascularization and bone regeneration in steroid-induced osteonecrosis of the femoral head. Joint Bone Spine. 2009;76(6):685–90. PubMed PMID: WOS:000273259900022.
doi: 10.1016/j.jbspin.2009.04.002
pubmed: 19576836
Sun YA, Feng Y, Zhang CQ, Cheng XG, Chen SB, Ai ZS, et al. Beneficial effect of autologous transplantation of endothelial progenitor cells on Steroid-Induced femoral head osteonecrosis in rabbits. Cell Transpl. 2011;20(2):233–43. https://doi.org/10.3727/096368910x522234 . PubMed PMID: WOS:000289322000008.
doi: 10.3727/096368910x522234
Guo SC, Tao SC, Yin WJ, Qi X, Sheng JG, Zhang CQ. Exosomes from human synovial-derived mesenchymal stem cells prevent glucocorticoid-Induced osteonecrosis of the femoral head in the rat. Int J Biol Sci. 2016;12(10):1262–72. https://doi.org/10.7150/ijbs.16150 . PubMed PMID: WOS:000385823300010.
doi: 10.7150/ijbs.16150
pubmed: 27766040
pmcid: 5069447
Zhu ZH, Song WQ, Zhang CQ, Yin JM. Dimethyloxaloylglycine increases bone repair capacity of adipose-derived stem cells in the treatment of osteonecrosis of the femoral head. Exp Ther Med. 2016;12(5):2843–50. https://doi.org/10.3892/etm.2016.3698 . PubMed PMID: WOS:000388822000007.
doi: 10.3892/etm.2016.3698
pubmed: 27882083
pmcid: 5103711
Yu HP, Zhu DY, Liu P, Yang QH, Gao JJ, Huang YG, et al. Osthole stimulates bone formation, drives vascularization and retards adipogenesis to alleviate alcohol-induced osteonecrosis of the femoral head. J Cell Mol Med. 2020;24(8):4439–51. https://doi.org/10.1111/jcmm.15103 . PubMed PMID: WOS:000527848000007.
doi: 10.1111/jcmm.15103
pubmed: 32135036
pmcid: 7176840
Zhu DY, Yu HP, Liu P, Yang QH, Chen YX, Luo PB, et al. Calycosin modulates inflammation via suppressing TLR4/NF-κB pathway and promotes bone formation to ameliorate glucocorticoid-induced osteonecrosis of the femoral head in rat. Phytother Res. 2021;35(5):2824–35. https://doi.org/10.1002/ptr.7028 . PubMed PMID: WOS:000610451800001.
doi: 10.1002/ptr.7028
pubmed: 33484002
Ding H, Gao YS, Hu C, Wang Y, Wang CG, Yin JM, et al. HIF-1α transgenic bone marrow cells can promote tissue repair in cases of Corticosteroid-Induced osteonecrosis of the femoral head in rabbits. PLoS ONE. 2013;8(5):12. https://doi.org/10.1371/journal.pone.0063628 . PubMed PMID: WOS:000319036100044.
doi: 10.1371/journal.pone.0063628
Zhang YL, Yin JH, Ding H, Zhang W, Zhang CQ, Gao YS. Vitamin K < sub > 2 prevents glucocorticoid-induced osteonecrosis of the femoral head in rats. Int J Biol Sci. 2016;12(4):347–58. https://doi.org/10.7150/ijbs.13269 . PubMed PMID: WOS:000369439500001.
doi: 10.7150/ijbs.13269
pubmed: 27019620
pmcid: 4807155
Chen YX, Zhu DY, Xu ZL, Yin JH, Yu XW, Mei J, et al. The Protective Effect of Cordycepin on Alcohol-Induced osteonecrosis of the femoral head. Cell Physiol Biochem. 2017;42(6):2391–403. doi: 10.1159/000480181. PubMed PMID: WOS:000415239800021.
doi: 10.1159/000480181
pubmed: 28848161
Chen YX, Zhu DY, Yin JH, Yin WJ, Zhang YL, Ding H, et al. The protective effect of PFTα on alcohol-induced osteonecrosis of the femoral head. Oncotarget. 2017;8(59):100691–707. https://doi.org/10.18632/oncotarget.19160 . PubMed PMID: WOS:000419561600128.
doi: 10.18632/oncotarget.19160
pubmed: 29246013
pmcid: 5725055
Zhou D, Chen YX, Yin JH, Tao SC, Guo SC, Wei ZY, et al. Valproic acid prevents glucocorticoid-induced osteonecrosis of the femoral head of rats. Int J Mol Med. 2018;41(6):3433–47. https://doi.org/10.3892/ijmm.2018.3534 . PubMed PMID: WOS:000430556300031.
doi: 10.3892/ijmm.2018.3534
pubmed: 29512684
pmcid: 5881807
Yu HP, Liu P, Zhu DY, Yin JH, Yang QH, Huang YG, et al. Chrysophanic acid shifts the differentiation tendency of BMSCs to prevent alcohol-induced osteonecrosis of the femoral head. Cell Prolif. 2020;53(8):12. https://doi.org/10.1111/cpr.12871 . PubMed PMID: WOS:000543784200001.
doi: 10.1111/cpr.12871
Chen YX, Tao SC, Xu ZL, Yin WJ, Zhang YL, Yin JH, et al. Novel akt activator SC-79 is a potential treatment for alcohol-induced osteonecrosis of the femoral head. Oncotarget. 2017;8(19):31065–78. https://doi.org/10.18632/oncotarget.16075 . PubMed PMID: WOS:000401003200035.
doi: 10.18632/oncotarget.16075
pubmed: 28415692
pmcid: 5458189
Yang QH, Yin WJ, Chen YX, Zhu DY, Yin JH, Zhang CQ, et al. Betaine alleviates alcohol-induced osteonecrosis of the femoral head < i > via mTOR signaling pathway regulation. Biomed Pharmacother. 2019;120:9. PubMed PMID: WOS:000499625900010.
doi: 10.1016/j.biopha.2019.109486
Yang F, Luo PB, Ding H, Zhang CQ, Zhu ZH. Collagen type V a2 (COL5A2) is decreased in steroid-induced necrosis of the femoral head. Am J Transl Res. 2018;10(8):2469–79. PubMed PMID: WOS:000443724100020.
pubmed: 30210685
pmcid: 6129523
Cui QJ, Wang GJ, Balian G. Pluripotential marrow cells produce adipocytes when transplanted into steroid-treated mice. Connect Tissue Res. 2000;41(1):45–. PubMed PMID: WOS:000088133400004.
doi: 10.3109/03008200009005641
pubmed: 10826708
Wiesmann A, Pereira P, Böhm P, Faul C, Kanz L, Einsele H. Avascular necrosis of bone following allogeneic stem cell transplantation:: MR screening and therapeutic options. Bone Marrow Transpl. 1998;22(6):565–9. https://doi.org/10.1038/sj.bmt.1701374 . PubMed PMID: WOS:000075968200008.
doi: 10.1038/sj.bmt.1701374
Tauchmanovà L, De Rosa G, Serio B, Fazioli F, Mainolfi C, Lombardi G, et al. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation -: a single center experience and a review. Cancer. 2003;97(10):2453–61. https://doi.org/10.1002/cncr.11373 . PubMed PMID: WOS:000182665900009.
doi: 10.1002/cncr.11373
pubmed: 12733144
Hisatome T, Yasunaga Y, Yanada S, Tabata Y, Ikada Y, Ochi M. Neovascularization and bone regeneration by implantation of autologous bone marrow mononuclear cells. Biomaterials. 2005;26(22):4550–6. PubMed PMID: WOS:000227743300007.
doi: 10.1016/j.biomaterials.2004.11.032
pubmed: 15722124
Shi ZB, Wang KZ. Effects of recombinant adeno-associated viral vectors on angiopoiesis and osteogenesis in cultured rabbit bone marrow stem cells via co-expressing hVEGF and hBMP genes: a preliminary study in vitro. Tissue Cell. 2010;42(5):314–21. PubMed PMID: WOS:000283399500006.
doi: 10.1016/j.tice.2010.07.007
pubmed: 20817238
Wang BL, Sun W, Shi ZC, Zhang NF, Yue DB, Guo WS, et al. Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg. 2010;130(7):859–65. https://doi.org/10.1007/s00402-009-0939-0 . PubMed PMID: WOS:000279297800008.
doi: 10.1007/s00402-009-0939-0
pubmed: 19621230
Wang YS, Wang YH, Zhao GQ, Li YB. Osteogenic potential of human calcitonin gene-related peptide alpha gene-modified bone marrow mesenchymal stem cells. Chin Med J. 2011;124(23):3976–81. https://doi.org/10.3760/cma.j.issn.0366-6999.2011 . .23.024. PubMed PMID: WOS:000299061300024.
doi: 10.3760/cma.j.issn.0366-6999.2011
pubmed: 22340327
Wen Q, Jin D, Zhou CY, Zhou MQ, Luo W, Ma L. HGF-Transgenic MSCs can improve the effects of tissue self-repair in a rabbit model of traumatic osteonecrosis of the femoral head. PLoS ONE. 2012;7(5):13. https://doi.org/10.1371/journal.pone.0037503 . PubMed PMID: WOS:000305343100037.
doi: 10.1371/journal.pone.0037503
Jia J, Feng XB, Xu WH, Yang SH, Zhang Q, Liu XZ, et al. MiR-17-5p modulates osteoblastic differentiation and cell proliferation by targeting SMAD7 in non-traumatic osteonecrosis. Exp Mol Med. 2014;46:8. https://doi.org/10.1038/emm.2014.43 . PubMed PMID: WOS:000342290700004.
doi: 10.1038/emm.2014.43
Gu CX, Xu Y, Zhang SF, Guan HY, Song S, Wang XL, et al. miR-27a attenuates adipogenesis and promotes osteogenesis in steroid-induced rat BMSCs by targeting PPARγ and GREM1. Sci Rep. 2016;6:12. https://doi.org/10.1038/srep38491 . PubMed PMID: WOS:000389125900001.
doi: 10.1038/srep38491
Yu ZF, Fan LH, Li J, Ge ZG, Dang XQ, Wang KZ. Lithium chloride attenuates the abnormal osteogenic/adipogenic differentiation of bone marrow-derived mesenchymal stem cells obtained from rats with steroid-related osteonecrosis by activating the β-catenin pathway. Int J Mol Med. 2015;36(5):1264–72. https://doi.org/10.3892/ijmm.2015.2340 . PubMed PMID: WOS:000364889400009.
doi: 10.3892/ijmm.2015.2340
pubmed: 26352537
pmcid: 4601745
Kong XY, Li XM, Zhang C, Zhu LL, Wan HY, Zhu J, et al. Aqueous fraction of Huogu Formula promotes osteogenic differentiation of bone marrow stromal cells through the BMP and wnt signaling pathways. Rejuv Res. 2016;19(6):509–20. https://doi.org/10.1089/rej.2015.1795 . PubMed PMID: WOS:000391834700008.
doi: 10.1089/rej.2015.1795
Song MY, Zhao DM, Wei S, Liu CX, Liu Y, Wang B, et al. The Effect of Electromagnetic fields on the proliferation and the osteogenic or adipogenic differentiation of mesenchymal stem cells modulated by Dexamethasone. Bioelectromagnetics. 2014;35(7):479–90. .21867. PubMed PMID: WOS:000342721600003.
doi: 10.1002/bem.21867
pubmed: 25145543
Yang Q, Zhao YH, Peng J, Lu SB, Guo QY, Ma XL, et al. Xenoimplantation of an extracellular-Matrix-Derived, Biphasic, Cell-Scaffold Construct for repairing a large femoral-head high-load-bearing Osteochondral defect in a Canine Model. Sci World J. 2014;10. https://doi.org/10.1155/2014/127084 . PubMed PMID: WOS:000333309700001.
Zhang L, Muheremu A, Bai XD, Cheng NT, Ma LF, Meng H, et al. Tracing stem cells with magnetic nanoparticles in the treatment for osteonecrosis of femoral head. J Nanosci Nanotechnol. 2016;16(9):9008–14. https://doi.org/10.1166/jnn.2016.12741 . PubMed PMID: WOS:000387085000014.
doi: 10.1166/jnn.2016.12741
Liao W, Ning Y, Xu HJ, Zou WZ, Hu J, Liu XZ, et al. BMSC-derived exosomes carrying microRNA-122-5p promote proliferation of osteoblasts in osteonecrosis of the femoral head. Clin Sci. 2019;133(18):1955–75. https://doi.org/10.1042/cs20181064 . PubMed PMID: WOS:000489990900002.
doi: 10.1042/cs20181064
Zhu WW, Guo MK, Yang W, Tang M, Chen TM, Gan DL, et al. CD41-deficient exosomes from non-traumatic femoral head necrosis tissues impair osteogenic differentiation and migration of mesenchymal stem cells. Cell Death Dis. 2020;11(4):21. https://doi.org/10.1038/s41419-020-2496-y . PubMed PMID: WOS:000530485500007.
doi: 10.1038/s41419-020-2496-y
Zuo RT, Kong LC, Wang MW, Wang WB, Xu J, Chai YM, et al. Exosomes derived from human CD34 < SUP>+ stem cells transfected with miR-26a prevent glucocorticoid-induced osteonecrosis of the femoral head by promoting angiogenesis and osteogenesis. Stem Cell Res Ther. 2019;10(1):14. https://doi.org/10.1186/s13287-019-1426-3 . PubMed PMID: WOS:000497705400003.
doi: 10.1186/s13287-019-1426-3
Nan K, Zhang YK, Zhang X, Li D, Zhao Y, Jing ZP, et al. Exosomes from miRNA-378-modified adipose-derived stem cells prevent glucocorticoid-induced osteonecrosis of the femoral head by enhancing angiogenesis and osteogenesis via targeting miR-378 negatively regulated suppressor of fused (Sufu). Stem Cell Res Ther. 2021;12(1):13. https://doi.org/10.1186/s13287-021-02390-x . PubMed PMID: WOS:000662701000001.
doi: 10.1186/s13287-021-02390-x
Chen XJ, Shen YS, He MG, Yang F, Yang P, Pang FX, et al. Polydatin promotes the osteogenic differentiation of human bone mesenchymal stem cells by activating the BMP2-Wnt/β-catenin signaling pathway. Biomed Pharmacother. 2019;112:10. PubMed PMID: WOS:000461449400125.
doi: 10.1016/j.biopha.2019.108746
Liao Y, Zhang P, Yuan B, Li L, Bao SS. Pravastatin protects against avascular necrosis of femoral Head via Autophagy. Front Physiol. 2018;9:13. https://doi.org/10.3389/fphys.2018.00307 . PubMed PMID: WOS:000429483500001.
doi: 10.3389/fphys.2018.00307
Li D, Wang DY, Yang YL, Gao PF, Fan WZ, Zhang XH, et al. Caffeic acid-deferoxamine self-polymerization coating on Ti Implant promotes osteointegration by Synergetic Regulation of multi-pathways in ONFH mechanism. Adv Funct Mater. 2023;33(26):16. https://doi.org/10.1002/adfm.202212016 . PubMed PMID: WOS:000952313800001.
doi: 10.1002/adfm.202212016
Fang B, Wang D, Zheng JQ, Wei QS, Zhan DX, Liu YM, et al. Involvement of tumor necrosis factor alpha in steroid-associated osteonecrosis of the femoral head: friend or foe? Stem Cell Res Ther. 2019;10:12. https://doi.org/10.1186/s13287-018-1112-x . PubMed PMID: WOS:000454902400005.
doi: 10.1186/s13287-018-1112-x
Zhou ZB, Pan CH, Wang N, Zhou LH, Shan HJ, Gao YS, et al. A high-fat diet aggravates osteonecrosis through a macrophage-derived IL-6 pathway. Int Immunol. 2019;31(4):263–73. https://doi.org/10.1093/intimm/dxz002 . PubMed PMID: WOS:000464940800007.
doi: 10.1093/intimm/dxz002
pubmed: 30779845
Cheng YN, Chen H, Duan P, Zhang H, Yu YL, Yu JD, et al. Early depletion of M1 macrophages retards the progression of glucocorticoid-associated osteonecrosis of the femoral head. Int Immunopharmacol. 2023;122:12. PubMed PMID: WOS:001050865000001.
doi: 10.1016/j.intimp.2023.110639